Tirabrutinib
Drug timelines are a Plus or Pro feature.
13 regulatory and trial events tracked for Tirabrutinib, covering 2020-01-22 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) [Phase 3]